NextCure Inc. has announced a one-for-twelve reverse stock split of its common stock, effective July 14, 2025. The stockholders approved an amendment enabling a reverse stock split at a ratio between one-to-five and one-to-fifteen, with the board of directors deciding on the final ratio. No fractional shares will be issued; instead, stockholders will receive cash for any fractional shares based on the closing price before the split. The common stock will trade on a split-adjusted basis on the Nasdaq Global Select Market under the ticker symbol "NXTC".
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。